Talimogene laherparepvec: First in class oncolytic virotherapy

• Egile Nagusiak: Robert M. Conry (Egilea), Brian Westbrook (Egilea), Svetlana McKee (Egilea), Timothy Graham Norwood (Egilea)
• Formatua: Liburua
• Argitaratua: Taylor & Francis Group, 2018-04-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Oncolytic viruses represent a novel drug class in which native or modified viruses mediate tumor regression through selective replication within and lysis of tumor cells as well as induction of systemic antitumor immunity capable of eradicating tumor at distant, uninjected sites. Talimogene laherpar...